Johann de Bono

Consultant at the Institute of Cancer Research

Professor Johann de Bono is Head of the Division of Clinical Studies and an international expert in the development of molecularly targeted cancer therapies against adult cancers. He runs one of the world’s largest phase I clinical trials units for cancer and has also led phase III trials of the prostate cancer drugs abiraterone and cabazitaxel.

Visit website:

See also: Academia Institute of Cancer Research

Johann de Bono News

An effective immunotherapy for advanced prostate cancer

BBC - 28-Nov-2019

Only 5% saw their tumours shrink, but may be more successful if used earlier


New drug slowed tumour growth in men with prostate cancer

BBC - 30-Sep-2019

Olaparib delays cancer growth by months, which means the increased lifespan


Drug attacks cancers cells using trojan horse antibody

Independent - 08-Feb-2019

Novel mechanisms for attacking cancer cells are always good news